Retrospective study of occurrence of same-day ARF after administration of different IGs and ascertained potential risk factors.
Phase of Trial: Phase IV
Latest Information Update: 17 Jan 2018
Price : $35 *
At a glance
- Drugs Immune globulin (Primary)
- Indications Immunodeficiency disorders
- Focus Therapeutic Use
- 17 Jan 2018 New trial record
- 01 Dec 2017 Results published in the Transfusion.